‘å‰ïƒvƒƒOƒ‰ƒ€
|
|
‘å‰ïƒvƒƒOƒ‰ƒ€ |
7ŒŽ24“úiŒŽj
‘æ
‚P
“ú
–Ú |
9:30 |
Žó•tŠJŽn |
10:00 |
VŠé‰æƒZƒbƒVƒ‡ƒ“
…ŠÔ r (CBIŠw‰ï2006”N‘å‰ï ‘å‰ïŽÀsˆÏˆõ’·)
10:05 |
ƒ‰Û‘è A„ |
|
’ñˆÄF“팴 —m”Vi“Œ‹ž‘åŠw‘åŠw‰@j
‰ñ“šF‰Á“¡ Šî_i’†ŠO»–òiŠ”jj |
10:35 |
ƒ‰Û‘è B„ |
|
’ñˆÄFˆêÎ ‰pˆê˜Yi“Œ–k‘åŠwj
‰ñ“šF”ü‘î ¬Ž÷i–¼ŒÃ‰®‘åŠwj
‰ñ“šF¬¼ ’qˆêiH“cŒ§—§‘åŠwj |
11:30 |
ƒ‰Û‘è C„ |
|
’ñˆÄF’߉ª ½i“Œ‹žH‰È‘åŠwj |
11:35 |
ƒ‰Û‘è D„ |
|
’ñˆÄFX ‹`—Ti‰ªŽR—‰È‘åŠwj |
|
11:50 |
ŠJ‰ïˆ¥ŽA
‘½“c K—Y (CBIŠw‰ï ‰ï’·) |
12:00 |
ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[FƒAƒhƒoƒ“ƒXƒ\ƒtƒgŽÐ |
13:15 |
ŠJ‰ïu‰‰
…ŠÔ r (CBIŠw‰ï2006”N‘å‰ï ‘å‰ïŽÀsˆÏˆõ’·) |
13:30 |
—̈æƒZƒbƒVƒ‡ƒ“ 1 (•ª–ì 1 & 2)
<Šî’²u‰‰ & µ‘Òu‰‰>
S01 |
13:30-14:15 |
|
–k‰Y ˜a•v (AIST)
"Quantum Chemical Calculations of Binding Energy between Protein and Ligand"
À’·F’†–ì ’B–çi‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Šj |
S02 |
14:15-15:00 |
|
•y–{ ¹Ž÷ (SGX Pharmaceuticals Inc.)
"Fragment-based Drug Discovery: Concept and Example"
À’·F‚‰ª —YŽii‘å³»–òiŠ”jj |
|
(15:00-15:30 Break) |
S03 |
15:30-16:30 |
|
Ruben Abagyan(The Scripps Research Institute)
"Computational Structural Proteomics and Drug Discovery"
À’·F’|“c-Žu‘é ^—RŽqi–k—¢‘åŠwj |
|
16:30 |
ƒ|ƒXƒ^[Œû“ª”•\ i6–¼ x 5•ªj
Poster ID: |
P1-03, |
P1-06, |
P2-01 |
P2-02, |
P3-03, |
P3-09 |
|
17:00
18:00 |
ƒ|ƒXƒ^[”•\F@“¢˜_ŽžŠÔiŠï””Ô†j |
|
7ŒŽ25“úi‰Îj
‘æ
‚Q
“ú
–Ú |
9:00 |
Žó•tŠJŽn |
9:30 |
‘å‰ïƒe[ƒ}u‰‰ 1 (Wet study of ADMET)
<Šî’²u‰‰ & µ‘Òu‰‰>
S04 |
9:30-10:30 |
|
Svein Oie (ƒWƒ‡[ƒWƒA‘åŠw)
"Optimizing use of Pharmacokinetics and Toxicokinetics in Drug Discovery"
À’·F…ŠÔ ri“Œ‹ž–ò‰È‘åŠwj |
S05 |
10:30-11:15 |
|
‹´“c@[ (‹ž“s‘åŠw)
"Development of DDS: Analysis and Control of Drug Disposition in the Body"
À’·F–x] —˜Ž¡iç—t‘åŠwj |
S06 |
11:15-12:00 |
|
¬–ì@“Ö (ˆã–òŠî”ÕŒ¤‹†Š)
"Current topics of toxicogenomics - Challenges on issues in Toxicogenomics
Project -"
À’·FL£ –¾•Fi‘—§ˆã–ò•iH•i‰q¶Œ¤‹†Šj |
|
12:00 |
ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[F•xŽm’ÊiŠ”j |
13:30 |
—̈æƒZƒbƒVƒ‡ƒ“ 2 (•ª–ì 3 & 4)
<Šî’²u‰‰ & µ‘Òu‰‰>
S07 |
13:30-14:30 |
|
Kyoung Tai No (‰„¢‘åŠw)
"Introduction of Integrated e-Drug Discovery System, Lead Explore"
À’·F¬’·’J º•Fi—‰»ŠwŒ¤‹†Šj |
S08 |
14:30-15:15 |
|
‹à’J d•F (“Þ—Çæ’[‰ÈŠw‹Zp‘åŠw‰@‘åŠw)
"KNApSAcK:Secondary metabolite database related between metabolites
and species"
À’·F¬’·’J º•Fi—‰»ŠwŒ¤‹†Šj
|
|
(15:15-15:45 Break) |
S09 |
15:45-16:30 |
|
‹gì Ÿ”ü(—Œ¤GSCj
""Pharmaco-Ontologies and their Roles"
À’·F¬’·’J º•Fi—‰»ŠwŒ¤‹†Šj |
|
16:30 |
ƒ|ƒXƒ^[Œû“ª”•\ i6–¼ x 5•ªj
Poster ID: |
P3-11, |
P4-02, |
P4-04 |
P5-07, |
P5-11, |
P5-16 |
|
17:00 |
ƒ|ƒXƒ^[”•\F@“¢˜_ŽžŠÔi‹ô””Ô†j |
18:00 |
ƒ|ƒXƒ^[Ü”•\ |
|
7ŒŽ26“úi…j
‘æ
‚R
“ú
–Ú |
9:00 |
Žó•tŠJŽn |
9:30 |
‘å‰ïƒe[ƒ}u‰‰ 2 (Dry study of ADMET)
<Šî’²u‰‰ & µ‘Òu‰‰>
S10 |
9:30-10:30 |
|
Sean Ekins(Arizona Commodity Traders, LLC & Univ. of Maryland)
"Combining Quantitative Structure Activity Relationships and Systems
Biology Approaches for in silico ADME/Tox"
À’·F‰ªè NŽiié‹Êˆã‰È‘åŠwƒQƒmƒ€ˆãŠwŒ¤‹†ƒZƒ“ƒ^[j |
S11 |
10:30-11:15 |
|
Edward H. Kerns (Wyeth Res.)
"Current Strategies for ADMET Integration to Enhance Efficiency and
Quality in Drug Discovery"
À’·FŽR‰º •x‹`i‹ž“s‘åŠwj |
S12 |
11:15-12:00 |
|
‘O“c ˜aÆ (“Œ‹ž‘åŠw)
"In silico database, simulation and prediction for the optimization of pharmacokinetic
properties of drug candidates" À’·F…ŠÔ ri“Œ‹ž–ò‰È‘åŠwj |
|
12:00 |
ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[F ƒZƒŒƒbƒvƒWƒƒƒpƒ“ |
13:30 |
—̈æƒZƒbƒVƒ‡ƒ“ 3 (•ª–ì 6 & 7)
<Šî’²u‰‰ & µ‘Òu‰‰>
S13 |
13:30-14:20 |
|
‚–ì –¾•F (‘—§î•ñŠwŒ¤‹†Š)
"Information Access based on Association"
i˜A‘z‚ÉŠî‚Âî•ñƒAƒNƒZƒX‹Zpj
À’·FŒ´“c ‹`‘¥i“ú—§»ìŠj |
S14 |
14:20-15:10 |
|
¬’r –ƒŽq (iŠ”j“ú—§»ìŠ’†‰›Œ¤‹†Š)
"Biomedical text mining: state of the art and future direction"
À’·FŒ´“c ‹`‘¥i“ú—§»ìŠj |
|
(15:10-15:25 Break) |
S15 |
15:25-16:15 |
|
‹g“c ‹P•Fi‘—§‚ª‚ñƒZƒ“ƒ^[Œ¤‹†Šj
"Cancer Genomics: Chip, SNP, Database"
À’·F“c’† ”Ži“Œ‹žˆã‰ÈŽ•‰È‘åŠwj |
S16 |
16:15-17:05 |
|
‰–“c –M˜Y (“Œ‹ž‘åŠw)
"Application of Epigenetics on Development of Drugs"
À’·F‰Í‡ —²—˜iƒG[ƒUƒCiŠ”jj |
|
17:10
17:30 |
•Â‰ï‚̈¥ŽA |
|